Significance Statement {#s1}
======================

At the first visual synapse, photoreceptor cells signal to two distinct bipolar cell (BC) populations, one characterized by a depolarizing response to light onset (ON or DBCs), the other by a hyperpolarizing response (OFF or HBCs). The DBC light response depends on a G protein-coupled metabotropic glutamate receptor (mGluR) and associated protein complex, known as the DBC signalplex. Loss of function mutations in signalplex proteins lead to loss of scotopic visual function, and causes congenital stationary night blindness (CSNB) in humans. Here we show how the loss of LRIT3, a previously identified signalplex protein, not only prevents functional assembly of the DBC signalplex, but also alters visual function through both ON and OFF signaling pathways.

Introduction {#s2}
============

Light signaling starts in the retina when photoreceptors detect a luminance increase, hyperpolarize, and decrease tonic glutamate release. Differences in rod and cone photoreceptor light sensitivity creates parallel channels that encode visual signals under dim and bright illumination, and signal through rod bipolar cells (BCs) and multiple types of cone BCs, respectively. The parallel cone BC pathways comprise depolarizing (ON or DBCs) and hyperpolarizing (OFF or HBCs) BCs that selectively encode light increments and decrements, respectively. This difference in response polarity results from the type of glutamate receptors expressed. Rod and cone ON BCs signal via metabotropic glutamate receptor 6 (mGluR6; [@B18]; [@B38]; [@B42]; [@B4]), whereas OFF BCs signal via AMPA/kainate receptor ([@B18]; [@B38]; [@B42]; [@B8]; [@B4]; [@B17]).

Mutations affecting rod photoreceptor presynaptic proteins generally disrupt the invaginating synapse and ribbon structure. These presynaptic disruptions correlate with ectopic extensions of DBC and HC dendrites into the ONL ([@B1]; [@B13]; [@B22]; [@B6]; [@B44]). In contrast, most mutations affecting postsynaptic DBC signalplex proteins do not alter the morphology of the invaginating ribbon synapse, although they disrupt light signaling due to their role in signal transduction ([@B23]; [@B2]; [@B25]; [@B20]; [@B31]; [@B29]). Many elements of the DBC signalplex are required for normal glutamate signaling, including: mGluR6, TRPM1, GPR179, nyctalopin, RGS7, RGS11, R9AP, Gα0, Gβ13, Gβ5, and LRIT3.

Most studies agree that functional interactions within the mGluR6 signalplex are similar in rod and cone DBCs, and that there is a dependence-hierarchy of DBC signalplex protein expression. For example, TRPM1 expression depends on expression of nyctalopin ([@B33]), and GPR179 is required for expression of RGS7, RGS11, and R9AP ([@B39]). Absence of the expression of RGS7, RG11 and R9AP does not disrupt expression of mGluR6, TRPM1, or nyctalopin ([@B36]; [@B39]). Leucine-rich repeat (LRR) containing protein LRIT3 is a recently discovered member of the signalplex with some structural and functional similarities to nyctalopin, including an apparent extracellular LRR domain. LRIT3 also contains two additional domains, a Fn3 and IgG, which are known to interact with many proteins ([@B19]). Functionally, loss of the protein leads to a no b-wave phenotype. However, unlike other known members of the RBC signalplex, LRIT3 is expressed in rod photoreceptors, and when its expression is restored in *Lrit3^-/-^* mouse rods, scotopic retinal function is rescued ([@B15]). These observations and the structure of LRIT3 raise the question of whether LRIT3 interacts with nyctalopin. Further, LRIT3's expression in photoreceptors suggests it could influence pre-, as well as postsynaptic signaling complexes ([@B15]). To examine the impact of the loss of LRIT3 on retina function, we created an *Lrit3^-/-^* mouse line and examined expression of key signalplex proteins and downstream retinal function.

Our data demonstrate that LRIT3 is required for nyctalopin localization to the DBC dendritic tips. LRIT3 is required for mGluR6 and GPR179 localization in in cone DBCs but not rod BCs. In addition to the expected lack of visual function in DBCs and ON retinal ganglion cells (RGCs), we found that visual responses of *Lrit3^-/-^* HBCs and OFF RGCs were significantly reduced.

Our results demonstrate that LRIT3 is the first protein whose absence impacts both ON and OFF signaling pathways without gross defects in the photoreceptor synaptic architecture. Because LRIT3 is necessary for assembling the postsynaptic DBC signalplex and for normal visual function signaling in both DBCs and HBCs, loss of LRIT3 impacts visual responses of nearly all RGCs.

Materials and Methods {#s3}
=====================

Animals {#s3A}
-------

All procedures were performed in accordance with the Society for Neuroscience policies on the use of animals in research and the University of Louisville Institutional Animal Care and Use Committee. Animals were housed in the University of Louisville AAALAC approved facility under a 12/12 h light/dark cycle. The mouse line described in these studies, *Lrit3^emrgg1^*, is referred to as *Lrit3^-/-^* throughout. The phenotypes of all the other lines have been published. *Trpm1^-/-^* (*Trpm1^tm1Lex^*, [@B41]), *Grm6^-/-^* ([@B23]), *Nyx^nob^* ([@B10]), *GPR179^nob5^* ([@B31]), *TgEYFP-Nyx* ([@B11]), *MitoP-CFP* ([@B24]), and *TgVsx1-cerulean* ([@B16]). All lines were backcrossed to C57BL/6J for at least 10 generations. The heterozygous lines of all these mice have no detectable phenotype, e.g., are indistinguishable from C57BL/6J; therefore, we used C57BL/6J, and heterozygous littermates as controls. Animals of either sex were used in all experiments. For all procedures, mice were anesthetized with an intraperitoneal or subcutaneous injection of ketamine/xylazine solution (127/12 mg/kg, respectively) diluted in normal mouse Ringer's or killed using CO~2~ according to AVMA guidelines.

Generation of *Lrit3^-/-^*mice with zinc finger nucleases (ZFNs) {#s3B}
----------------------------------------------------------------

C3H/HeNTac/C57BL/6NTac hybrid embryos (363) were injected with 10 ng/μl *Lrit3* ZFN mRNA and 254 viable embryos were implanted into nine Swiss Webster recipient mothers. Tail biopsies from offspring were collected and genomic DNA isolated using Direct Tail PCR solution (Thermo Scientific) supplemented with 0.2 μg/ml proteinase K (Thermo Scientific). Primers (5′- TAACCTGGGCATAGCCTGTC-3′; 5′-AAGGTCCAGGAAGGAGAAGG-3′) were used to amplify the ZFN targeted region (chr3:129503565, mm9). PCR fragments were either sequenced directly or cloned into the TopoBlunt vector (Invitrogen) and at least 10 clones sequenced. The *Lrit3^-/-^* allele was backcrossed onto C57Bl/6J mice for 10 generations.

Antibodies {#s3C}
----------

Guinea pig anti-LRIT3 and rabbit anti-TRPM1 antibodies were generated by immunizing animals with peptides (LRIT3:GELWTRRHRDDGERLLLC; TRPM1: SVVPEGQNTQQEKRSAETE) conjugated to KLH, by Biosynthesis Inc. Antibody, dilution and source are as following: LRIT3, 1:1000 ([@B15]); TRPM1, 1:1000 ([@B15]); Pikachurin, 1:2000 (Wako Chemicals; [@B40]); mGluR6, 1:2000 (gift, Dr. Kirill Martemyanov; [@B5]); and GFP for EYFP, 1:2000 (Cell Signaling catalog \#2555). The specificity of the LRIT3 and TRPM1 antibodies were validated by comparing immunostaining in control and *Lrit3^-/-^* and *Trpm1^-/-^* mice, respectively.

Cell culture, transfection, co-immunoprecipitation (IP), and immunoblotting {#s3D}
---------------------------------------------------------------------------

Human embryonic kidney (HEK293T) cells were cultured in high-glucose DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 50 IU/ml penicillin, and 50 μg/ml streptomycin. Cells were seeded on 60-mm culture dishes 1 d before transfection and transfected with a nyctalopin tagged with EYFP, and LRIT expression plasmids, using jetPrime reagent (Polyplus-transfection) according to the manufacturer's instructions. 48 h after transfection, cells were harvested in NP-40 lysis buffer (50 mM Tris, 150 mM NaCl, 2 mM EDTA, and 1% Nonidet P40, pH 8.0, supplemented with protease inhibitor cocktail; Sigma-Aldrich) and disrupted by rotating for 45 min at 4°C followed by sonication. Cell debris was removed by centrifugation at 17,000 × *g* for 15 min at 4°C, and the supernatant was collected and protein quantified using the Bradford reagent (Bio-Rad).

Co-IP was performed as described ([@B14]). Transfected HEK cell lysates (500 μg total protein in 200 μl) were precleared by incubating with 10 μl Dynabeads protein G (Invitrogen, ThermoFisher Scientific) at 4°C for 1 h. Precleared lysates were incubated with 5--10 μg of anti-LRIT3 antibody overnight at 4°C on an orbital rocker. A total of 45 μl of Dynabeads protein G was added and incubated for 2 h at 4°C. Dynabeads were collected and washed four times with Tris-buffered saline containing 0.3% Tween 20, and protein complexes eluted with 40 μl of 4× LDS loading buffer by incubation at 70°C for 10 min, loaded and analyzed on 4--12% NuPAGE gels (Invitrogen, ThermoFisher Scientific), transferred to PVDF membranes, and blocked with Odyssey Blocking buffer. Membranes were incubated with primary antibodies (guinea pig anti-LRIT3; 1:1000 and rabbit anti-GFP; 1:2000), diluted in Odyssey Blocking buffer, and washed four times with TBS containing 0.1% Tween 20 (TBST). After incubating with IRDye800 CW and IRDye680 CW-conjugated secondary antibodies diluted in Odyssey Blocking buffer (LI-COR), membranes were washed four times with TBST. Protein bands were visualized by scanning the membranes in an Odyssey Infrared Imaging System (LI-COR) using both 700- and 800-nm channels.

Retina preparation for immunohistochemistry {#s3E}
-------------------------------------------

Mice were killed by CO~2~ inhalation followed by cervical dislocation. Eyes were enucleated and the cornea and lens removed. The retina was dissected in PBS (pH 7.4) and fixed for 15--30 min in PBS containing 4% paraformaldehyde, then washed in PBS for 5 min, and cryoprotected in a graded series of sucrose solutions (5, 10, 15, and 20% in PBS) and finally in OCT:20% sucrose (2:1). The retinas were then frozen by immersion in an isopentane bath immersed in liquid nitrogen. Transverse 18-μm sections were cut on a cryostat (Leica Biosystems) and mounted on Superfrost Plus slides (ThermoFisher Scientific). Slides were stored at --80°C until used in immunohistochemistry experiments.

Immunohistochemistry methods have been described ([@B14]). Briefly, slides were dried at 37°C for 30 min, rinsed in PBS for 5 min, and then in PBX (PBS + 0.5% Triton X-100) for 5 min. Sections were incubated in blocking buffer (PBX + 5% normal donkey serum) for 1 h followed by overnight incubation with primary antibody in blocking buffer. Sections were washed 3 × 10 min in PBX, then incubated with secondary antibody diluted in blocking buffer for 1 h. Sections were washed 2 × 10 min in PBX and 1 × 10 min in PBS. Coverslips were mounted to slides using Vectashield (Vector Laboratories). Sections were imaged on an FV-3000 Confocal Microscope (Olympus) and corrected for contrast and brightness using Fluoview Software (Olympus) or Photoshop (Adobe Systems). Images shown in the figures are representative, of multiple images per section (typically two to three per section and four sections per slide, from at least three slides generated from each retina. Retinas from at least three mice are processed and examined. We typically collect oversampled *z*-stacks and the images shown are a representation of a flattened *z*-stack.

Electroretinography {#s3F}
-------------------

ERGs methods have been described ([@B36]). Briefly, mice were dark adapted overnight and anesthetized with a ketamine/xylazine solution (127/12 mg/kg, respectively) diluted in normal mouse Ringers and prepared for ERG recordings under dim red light. Pupils were dilated and accommodation relaxed with topical applications of 0.625% phenylephrine hydrochloride and 0.25% Tropicamide and the corneal surface anesthetized using 1% proparacaine HCl. Body temperature was maintained via an electric heating pad (TC1000 Temperature control, CWE Inc.). A clear acrylic contact lens with a gold electrode (LKC Technologies Inc.) was placed on the cornea and wet with artificial tears (Tears Again, OCuSOFT). Ground and reference needle electrodes were placed in the tail and on the midline of the forehead, respectively. For scotopic responses, flashes (from --3.6 to 2.1 log cd s/m^2^) were presented to dark adapted animals. For photopic responses the animals were light adapted (20 cd/m^2^) for 5 min and test flashes (from --0.8 to 1.9 log cd s/m^2^) were presented on this rod saturating background.

Rod BC recordings {#s3G}
-----------------

Methods for the preparation of retinal slices and whole cell recordings from BCs have been described ([@B36]). Briefly, isolated retinas were placed on nitrocellulose paper (Millipore Sigma) and ∼200-μm transverse slices were prepared using a tissue slicer, and placed in a heated recording chamber, which was constantly superfused with oxygenated Ringer's at 34--35°C. Recording electrodes with resistance measured between 6 and 9 MΩ were filled with Cs- gluconate intracellular solution (20 mM CsCl, 107 mM CsOH, 107 mM D-gluconic acid, 10 mM NaHEPES, 10 mM BAPTA, 4 mM ATP, and 1 mM GTP); 1% sulforhodamine was included in the intracellular solution to visualize and classify the cell based on its morphology ([@B9]).

Inhibitory blockers \[1 μM strychnine, 100 μM picrotoxin, and 50 μM 6-tetrahydropyridin-4-yl methylphosphinic acid (TPMPA)\] were included in bath solutions as was L-AP4 (4 μM) to saturate mGluR6 receptors.

OFF cone BC somas were targeted for whole cell patch clamp recording in Vsx1-cerulean reporter mice where type 1 and 2 HBCs (BC1 and BC2) are sparsely labeled ([@B16]). Only BC1s with an input resistance ∼1 GΩ and access resistance \<25 MΩ were used for recording and were voltage clamped at +50 mV ([@B26]; [@B41]). A Picospritzer II (Parker Instrumentation) was used to pressure apply drugs onto BC dendritic tips located in the outer plexiform layer (OPL). The drugs used were: the mGluR6 receptor antagonist α-cyclopropyl-4- phosphonophenylglycine (CPPG; 0.6 mM) or kainate (50 μm) to activate kainate receptors on HBCs. All reagents were purchased from Sigma-Aldrich, except for L-AP4 and kainate, which were purchased from Tocris Bioscience. Clampfit 10.2 was used for offline analyses of data. Currents were filtered off-line using a 20-Hz eight-pole Bessel low-pass filter.

Glutamate imaging {#s3H}
-----------------

To broadly target iGluSnFR expression to RGCs and amacrine cells, AAV2/1.*hSynapsin*.iGluSnFR in suspension was injected into the mouse eye, intravitreally (0.8--1.0 μl, 0.8--3.0 × 10^13^ vg/μl). Animals were killed 14--21 d after AAV injection and the retinas prepared as described ([@B3]). Isolated retinas were mounted photoreceptor-side down on a nitrocellulose filter paper disk (Millipore Sigma), with 1.0-mm-diameter holes for visual stimulation through the condenser, fixed in a perfusion chamber on a custom-built two-photon fluorescence microscope. Tissue was continuously perfused with oxygenated Ames medium at ∼6 ml/min; 34--36°C. Changes in iGluSnFR fluorescence, which represent the binding of glutamate to iGluSnFR, were measured as described ([@B3]), using a 60×, 1.0 NA, LUMPlanFl/IR objective (Olympus) and an ultrafast pulsed laser (Chameleon Ultra II; Coherent) tuned to 915 nm.

The visual stimulus used in imaging experiments comprised a contrast reversing spot (150 μm in diameter for BCs, 300 μm for GCs; 100% Michelson contrast; 1-Hz temporal modulation; 5-s duration) on a mid/high photopic intensity background (λmax = 395 nm; 5.8 × 10^4^ photons/μm^2^/s). Images (512 × 128 pixels) were acquired at 16 frames/s; line scans were collected at 2 kHz and presented down-sampled to 0.5 kHz. Fluorescence responses were quantified using custom algorithms in MATLAB (MathWorks).

RGC and off BC whole-cell recordings from retinal whole-mounts {#s3I}
--------------------------------------------------------------

Genetically identified OFF BC1 cells were recorded in the whole-mount retina of MitoP-CFP transgenic mice on *Lrit3^-/-^* or *Lrit3^+/-^* backgrounds. α-Type ON and α- and δ-type OFF ganglion cells were targeted for recording based on soma size in *Lrit3^-/-^* and *Lrit3^+/-^* whole-mount retina; cell type was verified *post hoc* using two-photon fluorescence imaging of sulforhodamine 101 filled cells as well as signature features of their recorded current responses. Visually-evoked excitatory and inhibitory currents of BCs and RGCs were recorded in whole-cell configuration at the reversal potential for chloride (--69 mV) and cations (0 mV), respectively, using conventional methods (Multiclamp 700B, Digidata 1550, PClamp10; MDS Analytical Technologies) and cesium-based internal pipette solution (90 mM cesium methanesulfonate, 5 mM TEA-Cl, 10 mM HEPES, 10 mM BAPTA, 3 mM NaCl, 2 mM QX-314, 4 mM ATP-magnesium salt, 0.4 mM GTP-sodium salt, and 10 mM Tris-phosphocreatine; pH 7.3, ∼284 mOsm). OFF BC membrane voltage responses were recorded in current clamp, using potassium-based internal solution (110 mM potassium methane sulfonate, 10 mM HEPES, 0.1 mM EGTA, 5 mM NaCl, 4 mM ATP-magnesium salt, 0.4 mM GTP-sodium salt, and 10 mM Tris-phosphocreatine; pH 7.3, ∼284 mOsm). Data were analyzed using custom algorithms in MATLAB.

Multielectrode array (MEA) recordings of RGCs {#s3J}
---------------------------------------------

Procedures for recording extracellular spiking activity of RGCs, using the MEA have been published ([@B32]). Mice were dark-adapted overnight, deeply anesthetized with IP injection of ketamine/xylazine and killed by cervical dislocation under dim red light. The retinas were dissected under dim red light in oxygenated Ringer's solution. The vitreous was removed by incubation (10 min) in Ringer's solution containing collagenase (12 U/μl) and hyaluronidase (50 U/μl; Worthington Biochemicals). Pieces in dorsal and ventral retina were dissected (2 × 2 mm) and placed ganglion cell side down on a sixty electrode MEA (60MEA200/30Ti; Multi Channel Systems). Retinal pieces were covered with a transparent cell culture membrane (ThermoFisher Scientific) and held in place with a platinum ring. The recording chamber was continuously perfused with oxygenated Ringer's solution 34--35°C throughout the experiment.

Before recording, the preparation was allowed to settle for ∼1 h in darkness. Spontaneous activity under dark-adapted conditions was recorded for 10 min followed by 10 or 20 trials of full-field light stimulation (5 s/2 s or 20 s/10 s interstimulus/stimulus interval, respectively). Light-adapted responses were recorded after 5 min of adaptation to a background of 3.01 cd/m^2^. Three flash intensities were used under dark- and for light-adapted conditions and presented in order of increasing luminance (scotopic levels: 0.01, 0.03, 1.58 cd/m^2^ and photopic levels: 2.71, 14.7 and 303 cd/m^2^).

Signals were bandpass filtered (80--3000 Hz) and digitized at 25 kHz (MC Rack software; Multi Channel Systems). When electrodes recorded spikes from more than one RGC, we sorted spikes using a principal components analysis (Offline Sorter; Plexon). Sorted units were exported, spikes binned (50 ms), and their spontaneous and visually evoked responses were analyzed (NeuroExplorer; Nex Technologies). Spontaneous activity was examined for the presence of rhythmic activity using a power spectral density FFT analyses (NeuroExplorer) with 4096 frequency values and a Hann window function. The mean FFT was smoothed using a Gaussian filter with a bin width of 30 ms. The frequency of the FFT peak was plotted as a function of power in arbitrary units (A.U.). Using custom scripts, we defined light evoked responses as a response with a peak firing rate that was \>+10 SEM above mean spontaneous. The time to peak (TTP) of the evoked response was defined as the time after stimulus onset when the peak firing rate reached it maximus.

Raster plots show responses to each stimulus presentation and peristimulus time histograms (PSTHs) represent the average spiking rate across all stimulus presentations.

Statistical Analyses {#s3K}
--------------------

Prism 8.2 software (GraphPad Software, Inc.) was used to perform the statistical analyses as suited for the necessary comparisons: two-way repeated measures ANOVAs, two-way ANOVAs, one-way ANOVAs, or *t* tests. Tukey *post hoc* tests were used when appropriate. Statistical significance was determined at *p* \< 0.05. When comparing peak firing rate and TTP data, Kruskal--Wallis tests were used. The specific tests used are indicated in the figure legends.

Results {#s4}
=======

The absence of LRIT3 causes complete congenital stationary night blindness (cCSNB) in humans and mice ([@B35]; [@B45]; [@B28]). We now report a likely mechanism of action and the downstream consequences of its absence.

LRIT3 is required for expression of and interacts with nyctalopin {#s4A}
-----------------------------------------------------------------

We and others have observed that TRPM1 is not expressed in *Lrit3^-/-^* retina ([@B27]; [@B15]), and it has been shown that the expression and correct localization of TRPM1 to the photoreceptor to BC synapse depends on the expression of nyctalopin ([@B33]). This raises the question; does TRPM1 expression depend on LRIT3 directly or is its expression lost due to a concomitant loss of nyctalopin? To address this, we examined the expression pattern of nyctalopin in *Lrit3^-/-^* and control retinas. Because there are no nyctalopin antibodies we crossed and backcrossed *Lrit3^-/-^* mice to a transgenic mouse line (*TgEYFP-Nyc*) that expresses an EYFP tagged nyctalopin fusion protein (EYFP-nyctalopin) in ON BCs ([@B11]). Consistent with the published data, control *TgEYFP-Nyc* retina showed immunopositive expression of EYFP-nyctalopin in the OPL, where it co-localized with both LRIT3 and the synaptic marker, pikachurin ([Fig. 1*Ai*](#F1){ref-type="fig"}), consistent with localization on the dendritic tips of rod and cone DBCs. In *Lrit3^-/-^/TgEYFP-Nyc* retinas EYFP-nyctalopin expression was absent ([Fig. 1*Aii*](#F1){ref-type="fig"}), although these mice carried a copy of the EYFP-nyctalopin transgene. This result shows LRIT3 is required for nyctalopin expression at the DBC dendritic tips, in addition to TRPM on DBCs and mGluR6, GPR179 and RGS complex proteins in cone ON BCs (Extended Data [Figs. 1-1](#fig1-1){ref-type="supplementary-material"}, [1-2](#fig1-2){ref-type="supplementary-material"}; [@B35]; [@B27]; [@B15]).

![LRIT3 interacts with and is required for nyctalopin expression. ***A***, Confocal fluorescence image of EYFP-nyctalopin (red), LRIT3 (green) and pikachurin (magenta) staining in (***Ai***) control and (***Aii***) *Lrit3^-/-^/TgNyc-EYFP* retinas. Nyctalopin-EYFP is not expressed in the *Lrit3^-/-^/TgNyc-EYFP* retina. Characteristics of the *Lrit3^-/-^* mouse are shown in Extended Data [Figures 1-1](#fig1-1){ref-type="supplementary-material"}, [1-2](#fig1-2){ref-type="supplementary-material"}. ***B*,** In *Nyx^nob^* retinas that lack nyctalopin, LRIT3 is expressed and localized to the dendrites of the rod and cone DBCs (marked by arrowheads). Examples show representative images of data from at least three mice. ***C***, LRIT3 and nyctalopin interact in HEK293 cells. HEK293 cells were transfected with expression plasmids *pLrit3*, *pNyx-EYFP* or both, and immunoblotted with antibodies against LRIT3 and EYFP. Lanes for the lysates show that the expected proteins were expressed. The remaining lysate was immunoprecipitated (IP) with antibodies against LRIT3 and the precipitates analyzed by western blotting. An asterisk indicates a non-specific band. Blots are representative of at least three experiments.](enu9992031820001){#F1}
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LRIT3 is required for normal ERGs and is expressed in the OPL. ***A***, Schematic of the *Lrit3* gene indicating the target region (\*) for the ZFN and resulting 40 bp deletion in the *Lrit3^-/-^* mouse line. ***B***, Electroretinograms of control (black symbols) and *Lrit3^-/-^* (red symbols) mice under scotopic and (***C***) photopic conditions. Example response waveforms for five (scotopic) and three (photopic) luminance steps are shown, as well as summary data for all luminance steps. The *Lrit3^-/-^* mice have a normal a-wave that is similar in amplitude control mice (*p* \> 0.05 at all flash intensities, *t* tests followed by Bonferroni correction for multiple testing). In contrast, *Lrit3^-/-^* mice lack the b-wave under both scotopic and photopic conditions. The control b-wave amplitude is significantly greater than 0 at all flash intensities (*p* \> 0.05 one sample *t* tests followed by Bonferroni correction for multiple testing). ***D***, DIC (left) and immunohistochemical staining for LRIT3 in transverse sections from the control mouse retina. ***E***, LRIT3 staining of OPL of control and *Lrit3^-/-^* retinas. ***F***, Western blotting for LRIT3 and a loading control β-actin in control and *Lrit3^-/-^* retinas. These data validate the specificity of the LRIT3 antibody is specific. ***G***, TRPM1 (green) is mislocalized in *Lrit3^-/-^* OPL and Pikachurin expression is the same as control. These are representative images of data from at least four mice. OS, outer segments; INL, inner nuclear layer; GC, ganglion cell layer. Download Figure 1-1, TIF file.
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The absence of LRIT3 has differential effects on rod and cone DBC signalplex proteins. Immunohistochemical staining for GPR179, mGluR6, Gβ5, RGS7, RGS11, and R9AP show punctate staining at the dendritic tips of both rod and cone (large clusters at the base of the OPL and indicated by arrowheads) DBCs in control mice. In *Lrit3^-/-^* mice these proteins are localized on the rod DBC dendritic tips but are absent from the cone DBCs. Note the lack of the large clusters at the bottom of the OPL. Scale bar = 5 μm. INL, inner nuclear layer. Scale bar = 5 μm. Download Figure 1-2, TIF file.

We next tested whether LRIT3 expression depends on nyctalopin by examining its expression in *Nyx^nob^* mutant mice, which lack nyctalopin expression. *Nyx^nob^* and control retina ([Fig. 1*B*](#F1){ref-type="fig"}) have a similar distribution of immunopositive profiles in the OPL for both LRIT3 and pikachurin, and these profiles co-localize with the rod and cone DBC (arrowheads) tips. In contrast, TRPM1 expression is absent on *Lrit3* ^-/-^ DBC dendritic tips (Extended Data [Fig 1-1*G*](#fig1-1){ref-type="supplementary-material"}), although expression is present in the soma as reported ([@B33]). We conclude that nyctalopin expression depends on LRIT3 expression, and that the loss of TRPM1 from the dendritic tips of *Lrit3* ^-/-^ rod and cone DBCs results from the loss of nyctalopin expression. Given that LRIT3 expression in rods can restore function to *Lrit3^-/-^* rod BCs ([@B15]) we determined whether LRIT3 and nyctalopin interact. We expressed each protein alone or in combination in HEK293 cells, prepared cell lysates and did IPs. Cell lysates and immunoprecipitated proteins were run on western blots and probed using antibodies to LRIT3 and EYFP-nyctalopin ([Fig. 1*C*](#F1){ref-type="fig"}). After IP of LRIT3, staining for EYFP-nyctalopin is only present when both proteins are expressed, indicating the two proteins interact in this heterologous expression system.

LRIT3 expression is independent of other DBC signalplex components {#s4B}
------------------------------------------------------------------

The results from many labs suggest that there is a complex interdependency among the DBC signalplex components mGluR6, GPR179, TRPM1, and nyctalopin (for review, see [@B12]). To examine LRIT3 in this interdependency, we determined whether either mGluR6, GPR179 or TRPM1 were required for LRIT3 expression by staining for LRIT3 in *Grm6^-/-^*, *Gpr179^-/-^*, and *Trpm1^-/-^* mouse retinas. Similar to nyctalopin, LRIT3 expression was the same in control and each mutant mouse retina ([Fig. 2](#F2){ref-type="fig"}). Thus, LRIT3 trafficking and localization is independent of mGluR6, GPR179, TRPM1, and nyctalopin expression at the synapse between photoreceptors and BCs ([Fig. 2](#F2){ref-type="fig"}). In addition to pikachurin, an extracellular matrix-like protein located in the photoreceptor synaptic cleft, we also verified that the presynaptic proteins CACNA1F and cone arrestin (mCAR), had normal immunoreactivity in the *Lrit3^-/-^* OPL (Extended Data [Fig. 2-1](#fig2-1){ref-type="supplementary-material"}). In contrast, we also find a dramatic decrease in PNA staining in *Lrit3^-/-^*, consistent with previous observations (Extended Data [Fig. 2-1](#fig2-1){ref-type="supplementary-material"}; [@B27]). These data show that the absence of LRIT3 not only impacts the postsynaptic ON bipolar signalplex, but also alters expression of at least one presynaptic protein. *Lrit3^-/-^*RGC light evoked signaling is abnormal in other "no b-wave" mutant mouse models of cCSNB, RGCs show several abnormalities in spontaneous and visually evoked activity (*Nyx^nob^* and *Grm6^-/-^*; [@B7]; [@B32]). Abnormalities include a decrease in the proportion of cells that response to light onset (ON), as well as a significant delayed TTP in those RGCs that retain a response to light onset (dON). In addition, most RGCs have a dominant rhythmic bursting component in both their spontaneous and light evoked activity. Notably, *Nyx^nob^* and *Grm6^-/-^* RGCs retain responses to light offset (OFF) that are the same as control.

![LRIT3 and Pikachurin are expressed normally in the OPL of *Grm6^-/-^*, *Gpr179^nob5^*, and *Trpm1^-/-^*mouse retinas. Confocal fluorescence images of retinas from control, *Lrit3^-/-^*, *Grm6^-/-^*, *Gpr179^nob5^*, and *Trpm1^-/-^* mouse retinas, immunostained for LRIT3 (green) and pikachurin (magenta). The merged images show that LRIT3 and Pikachurin co-localize. Staining for CACNA1F, PNA, and mCAR (cone arrestin) are shown in Extended Data [Figure 2-1](#fig2-1){ref-type="supplementary-material"}. Arrowheads indicate cone terminals. Scale bar = 5 μm.](enu9992031820002){#F2}
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Cone terminal appear normal in *Lrit3^-/-^*retinas. ***A***, Immunohistochemical staining for the presynaptic markers CACNA1F and PNA. CACNA1F staining in *Lrit3^-/-^* retinas is indistinguishable from controls. PNA staining in *Lrit3^-/-^* retinas is decreased, but not completely absent. ***B***, Staining for the cone terminal marker mCAR (cone arrestin) and PNA. mCAR staining in the *Lrit3^-/-^* retinas is similar to controls, and PNA is decreased in *Lrit3^-/-^* retinas. Download Figure 2-1, TIF file.

We surveyed the responses of ∼1000 RGCs in *Lrit3^-/-^*, *Grm6^-/-^* and control retinas using a MEA. To optimize stimulus conditions, we first evaluated responses in a subset of these RGCs to flashes at several luminance intensities in dark-adapted and in light-adapted retinal whole-mounts ([Fig. 3*A*](#F3){ref-type="fig"}). The dimmest scotopic flash (0.004 cd/m^2^) evoked responses in a small proportion of RGCs across these three genotypes. The next brightest scotopic flash (0.03 cd/m^2^) evoked responses in significantly fewer *Grm6^-/-^* and *Lrit3^-/-^* RGCs compared to control. All of the other scotopic and photopic stimuli evoked responses in significantly fewer *Grm6^-/-^* and *Lrit3^-/-^* RGCs compared to control (*p* \< 0.05, Fisher exact tests with Bonferroni correction). We also found a large and unexpected difference in the percentage of *Lrit3^-/-^* versus *Grm6^-/-^* NR RGCs, e.g., there were significantly more NR *Lrit3^-/-^* versus *Grm6^-/-^* RGCs (50% and 10%, respectively; Fishers *p* \< 0.0001). The observed differences in the proportions of NR RGCs prompted us to examine other aspects of the *Lrit3^-/-^* mouse visually evoked responses. Using the brightest photopic flash stimulus (303 cd/m^2^), we subdivided the visually responsive RGCs in each of the three genotypes (control, *Lrit3^-/-^* and *Grm6^-/-^*) into three functional groups ([Fig. 3*C*](#F3){ref-type="fig"}): (1) RGCs with responses to light onset (ON, top row), which could be subdivided into ON or delayed ON (dON, TTP \> 500 ms); (2) RGCs with a response to light offset (OFF, middle row); and (4) RGCs with a response to light onset and offset (ON/OFF, bottom row). Among the visually responsive control RGCs, 47% increased spiking at light onset; 27% increased spiking at light offset; and 20% increased spiking to both luminance changes. Against this baseline, we compared responses in *Lrit3* ^-/-^ and *Grm6^-/-^* RGCs, which share a no b-wave phenotype. The mutant RGC response types differed strikingly from control ([Fig. 3*B*](#F3){ref-type="fig"}). As expected from a no b-wave phenotype, neither *Lrit3^-/-^* nor *Grm6^-/-^* RGCs showed short latency ON responses, although both had RGC ON responses with significantly delayed onsets compared to control (\>0.5 s, TTP; 9% in *Lrit3^-/-^* vs 31% in *Grm6^-/-^* RGCs).

![Visual responses of *Lrit3^-/-^*RGCs are significantly altered compared to controls and *Grm6^-/-^*. ***A***, Intensity response functions of control, *Lrit3^-/-^*, and *Grm6^-/-^* RGCs. Break in the *x*-axis represents 5-min light adaptation to a background of 3.01 cd/m^2^. ***B***, RGC functional classes in control, *Lrit3^-/-^* and *Grm6^-/-^* retinas based on responses to a 303 cd/m^2^ full field flashes on a 0.3 cd/m^2^ background. The total number of RGCs for each genotype is shown on the *x*-axis and were obtained from 12 retinal pieces from eight control mice, 16 retinal pieces from 6 *Lrit3^-/-^* mice, and 10 retinal pieces from four *Grm6^-/-^* mice, respectively. There are significantly more visually non-responsive RGCs (defined as cells with spontaneous but no visually evoked activity) in the *Lrti3^-/-^* mice than either control or *Grm6^-^/-*(∼50% increase; Fishers exact test, *p* \< 0.001 for both comparisons). ***C***, Representative average PSTHs (above, raster plots to individual stimulus presentation) of responses to a full field light stimulus (303 cd/m^2^) on a 0.3 cd/m^2^ background, recorded on a MEA. ***Ci***, Control RGC responses can be classified as ON, OFF, and ON/OFF based on whether spiking peaks to light onset, offset or both, respectively. All responses occur \<0.4 s after stimulus onset. *Lrit3^-/-^* (***Cii***) and *Grm6^-/-^* (***Ciii***) RGC responses can be classified into the same general groups but the time to the peak response to light onset is \>0.4 s (summary data not shown), and these responses are referred to as delayed ON (dON) or dON/OFF RGCs. ***D***, The peak amplitude of OFF RGCs in *Lrit3^-/-^* and *Grm6^-/-^* are decreased compared to controls (median: 25 and 19 Hz, respectively, vs 38 Hz in controls, Kruskal--Wallis followed by Dunn's test; *p* \< 0.001 for both comparisons). ***E***, Distribution of response latencies in the OFF *Lrit3^-/-^* and *Grm6^-/-^* RGCs is not different from control (Kruskal--Wallis *p* = 0.995 for both comparisons). ***F***, OFF responses in *Lrit3^-/-^* RGCs are mediated by kainate receptors. Responses show 37 RGCs peak response (sp/s), before (32 ± 1.6 SEM), during (2.4 ± 1.1), and after ACET (20.11 ± 1.1; 1.0 μM) treatment. ***G***, Fast Fourier transform to quantify rhythmicity in the spontaneous activity of *Lrit3^-/-^* and *Grm6^-/-^* RGCs. *Lrit3^-/-^* cells exhibit rhythmic firing, whereas few do so in the *Grm6^-/-^* retinas.](enu9992031820003){#F3}

The large number of *Lrit3^-/-^* NR cells suggests that sensitivity of the visual response may be impacted by the loss of LRIT3 expression. To examine this, we compared the peak response of RGCs across genotype. Peak responses in *Lrit3^-/-^* OFF RGCs were significantly smaller than control (median = 24.7 sp/s, *n* = 242 vs median = 37.6 sp/s, *n* = 86), although they were larger than *Grm6* ^-/-^ RGCs (18.5 sp/s, *n* = 241 ([Fig. 3*D*](#F3){ref-type="fig"}); Kruskal--Wallis, all comparisons *p* \< 0.0001). In contrast, the TTP response of OFF RGCs was similar across genotypes ([Fig. 3*E*](#F3){ref-type="fig"}; Kruskal--Wallis, *p* = 0.995). Among the few *Lrit3^-/-^* ON/OFF RGCs, the TTP firing at light onset (median = 660 ms, *n* = 8) was significantly delayed compared to control (median = 250 ms, *n* = 263) and was similar to *Grm6^-/-^* RGCs (median = 550 ms, *n* = 35; [@B32]).

Since crossover input from the ON pathway is absent, we could use the kainate receptor antagonist ACET (1 μM; [Fig. 3*F*](#F3){ref-type="fig"}) to verify that the *Lrit3^-/-^* OFF RGCs responses were in fact initiated in the OFF signaling pathway. We compared light evoked responses in control bath solution to the same RGCs in the presence of ACET. Of 515 *Lrit3^-/-^* RGCs, 180 (35%) had visually evoked OFF responses in control solution and only 11 (6%) retained that response after addition of ACET to the bath. Further, all OFF RGCs showed a reduction in peak response amplitude (∼43% of control). After 1-h wash, 37 RGCs recovered their OFF response. These data demonstrate that light evoked *Lrit3^-/-^* OFF responses.

*Nyx^nob^* RGCs show rhythmic bursting in their spontaneous activity, which also is superimposed on their light evoked responses ([@B7]). This activity is absent from *Grm6^-/-^* RGCs ([@B37]). Both the poststimulus time histograms and the raster plots ([Fig. 3*Cii*](#F3){ref-type="fig"}) suggest that rhythmic activity is present in *Lrit3^-/-^* RGCs and a fast Fourier transform was used to extract this activity and we found *Lrit3^-/-^* RGCs have a frequency between 3 and 8 Hz, similar to *Nyx^nob^* RGCs ([Fig. 3*G*](#F3){ref-type="fig"}) and the rhythmicity is present in visually responsive and NR *Lrit3^-/-^* RGCs. Under the same recording conditions, the few *Grm6^-/-^* RGCs that did have rhythmic activity ([Fig. 3*G*](#F3){ref-type="fig"}; 24/585) had fundamental frequencies between 5.6 and 9 Hz, but the modulation amplitude was ∼3-fold lower compared with *Lrit3^-/-^* RGCs ([Fig. 3*G*](#F3){ref-type="fig"}).

*Lrit3^-/-^* inner plexiform layer (IPL) shows no on and reduced off glutamate release {#s4C}
--------------------------------------------------------------------------------------

The large number of *Lrit3^-/-^* OFF RGCs with reduced peak firing rates led us to examine light-evoked glutamate release from BC axon terminals in the IPL sublaminae. The fluorescent glutamate sensor iGluSnFR was expressed in RGCs and amacrine cells using viral transduction, and changes in iGluSnFR fluorescence in the middle of the ON and OFF sublaminae were imaged during visual stimulation using two-photon fluorescence microscopy ([Fig. 4*A*](#F4){ref-type="fig"}; [@B3]). At light onset and offset, control retinas showed robust fluorescence responses in both the ON (ON responses) and OFF IPL sublaminae (OFF responses), reflecting glutamate release from ON and OFF-BCs, respectively ([Fig. 4*B*](#F4){ref-type="fig"}). In the *Lrit3^-/-^* IPL, glutamate release was negligible in the ON sublamina compared to control (--0.017 ± 0.006, *n* = 35; eight eyes vs 0.194 ± 0.017, *n* = 37; seven eyes; *t* test, *p* \< 0.0001; [Fig. 4*B*](#F4){ref-type="fig"}). Although we observed unambiguous stimulus modulated glutamate release in the *Lrit3^-/-^* OFF sublamina, following light decrements, the amplitude of these responses (ΔF/F) was reduced compared with control (0.086 ± 0.012, *n* = 40; eight eyes vs 0.187 ± 0.026, *n* = 28; seven eyes; *t* test, *p* = 0.0002; [Fig. 4*B*,*C*](#F4){ref-type="fig"}), which is consistent with our MEA results.

![Glutamate release in *Lrit3^-/-^*mice is decreased in both ON and OFF sublaminae of the IPL. ***A***, iGluSnFR expression in somas, and dendrites in the ON and OFF sublaminae of the IPL following viral transduction with AAV2/1-*hsyn*-iGluSnFR. ***B***, Visually-evoked changes in glutamate levels as detected by changes in iGluSnFR fluorescence in the ON (top traces) and OFF (bottom traces) layers of the IPL for control (black) and *Lrit3^-/-^* (red) retinas, to a contrast reversing spot on a photopic background (1.2 × 10^4^ R\*/rod and cone/s; 150 μm in diameter, 1-Hz square wave, 100% Michelson contrast). ***C***, Summary data for the change in iGluSnFR fluorescence in the ON and OFF sublaminae of control and *Lrti3^-/-^* retinas for all recorded areas (ON, control *n* = 37, seven eyes; *Lrit3^-/-^ n* = 35, eight eyes; OFF, control *n* = 28, seven eyes; *Lrit3^-/-^ n* = 40, eight eyes). ***D***, Whole-cell electrophysiological recordings of light-evoked current responses of three identified RGC types (same stimulus as in ***B***, except diameter 350 μm; recorded in voltage clamp mode at the reversal potential for chloride, --69 mV). ***E***, ***F***, Summary data for the light-evoked current response amplitude for all recorded cells. ON and OFF response amplitudes (***E***) were computed as the mean of the recorded current following a light increment and decrement, respectively (light and dark gray regions in ***D***). For all responses the amplitude of the excitatory (inward) current is inverted for ease of interpretation. Response amplitudes from control versus *Lrit3^-/-^* were compared using a *t* test (ON α ON response, control *n* = 7, five eyes vs *Lrit3^-/-^ n* = 15, eight eyes, *p* \< 0.0001; OFF α OFF response; control *n* = 7, five eyes vs *Lrit3^-/-^ n* = 8, six eyes, *p* \< 0.0007; OFF δ OFF response control *n* = 4, four eyes, *Lrit3^-/-^ n* = 6, four eyes, *p* = 0.086). TTP of the OFF responses of OFF-α and OFF-δ ganglion cells (***F***) were defined as the time following onset of a light decrement (dark gray region in ***D***) when the excitatory current peaked. TTP of control versus *Lrit3^-/-^* were compared using a *t* test (OFF α OFF response; control *n* = 7, five eyes vs *Lrit3^-/-^ n* = 8, six eyes, *p* = 0.183; OFF δ OFF response control *n* = 4, four eyes, *Lrit3^-/-^ n* = 6, four eyes, *p* = 0.0.371). All error bars are mean ± SEM. \* = Significant difference.](enu9992031820004){#F4}

To understand the changes underlying the reduced light signaling in ON and OFF pathways, we compared control and *Lrit3^-/-^* ON α, OFF α, and OFF δ RGCs using whole-cell voltage clamp recordings in whole-mount retina preparations ([Fig. 4*D*](#F4){ref-type="fig"}). RGC identity was confirmed based on dendritic morphology from fills with sulforhodamine 101, included in the intracellular pipette solution.

Clamped at the reversal potential for chloride (ECl; --69 mV), control ON α RGCs showed a robust inward (excitatory) current at light onset (ON response) and suppression of tonic inward current at light offset (OFF response), reflecting the stimulus-evoked modulation of glutamate release from presynaptic ON BCs. In *Lrit3^-/-^* ON α RGCs, the inward current at light onset was lost compared to control (33.4 ± 12.6 pA, *n* = 15; eight eyes vs --352.1 ± 32.4 pA, *n* = 7; five eyes; *t* test, *p* \< 0.0001; [Fig. 4*E*](#F4){ref-type="fig"}). In addition, in *Lrit3^-/-^* ON α RGCs the suppression following light offset was replaced by a small transient inward current in the *Lrit3^-/-^* cells (--78.4 ± 30.9 pA, *n* = 15; eight eyes vs 322.6 ± 64.1 pA, *n* = 7; five eyes; *t* test, *p* \< 0.0001). The emergence of an excitatory OFF response in ON α GCs is likely to result from AII amacrine-cell mediated signaling from OFF BCs to ON BCs, but was not investigated further. Clamped at the reversal potential for chloride (ECl; --69 mV), control OFF α and OFF δ RGCs showed inward currents at light offset, as expected ([@B4]). Although the response polarity and timing in *Lrit3^-/-^* OFF α RGCs were similar to control, response amplitude was reduced significantly (--222.8 ± 25.7 pA, *n* = 8; six eyes vs --603.2 ± 87.4 pA, *n* = 7; five eyes; *t* test, *p* = 0.0007), whereas in the OFF δ RGCs responses in *Lrit3^-/-^* and control OFF were similar (--104.5 ± 20.4 pA, *n* = 6; four eyes vs --163.1 ± 20.0 pA, *n* = 4; four eyes; *t* test, *p* = 0.086; [Fig. 4*E*](#F4){ref-type="fig"}). Also note that there are oscillations in the response in the *Lrit3^-/-^* OFF α and δ RGCs ([Fig. 4*D*](#F4){ref-type="fig"}, arrowheads) that are absent from control RGCs.

In sum, our electrophysiological recordings show that *Lrit3^-/-^* ON α RGCs lack excitatory synaptic input at light onset, as expected from their no b-wave phenotype and the absence of ON RGC spiking responses. What is novel about this no b-wave model is that the amplitudes of light-evoked. excitatory currents in at least one identified OFF RGC type are reduced, consistent with a decrease in their spiking activity. Collectively, the MEA and voltage clamp data suggest that light-evoked responses of many *Lrit3^-/-^* OFF RGCs are less sensitive to light compared to control RGCs, although the magnitude of the impact may vary with OFF RGC type. Given that LRIT3 is not expressed in the IPL (Extended Data [Fig. 1-1*D*](#fig1-1){ref-type="supplementary-material"}), it is possible that *Lrit3^-/-^* OFF RGCs have reduced synaptic input from the presynaptic OFF BCs.

ON and OFF *Lrit3^-/-^*BC function is abnormal {#s4D}
----------------------------------------------

To determine whether ON pathway excitatory input to ON α RGCs is eliminated, we assessed TRPM1 mediated currents in *Lrit3^-/-^* ON rod BCs, using whole cell recordings ([Fig. 5*A*](#F5){ref-type="fig"}). We simulated dark by bathing retinal slices in L-APB to activate mGluR6 and close TRPM1, then inactivated the mGluR6 to TRPM1 cascade by puffing on CPPG to gate TRPM1 ([@B41]). In control rod BCs, CPPG mediated a robust current (81.5 ± 7.1 pA, *n* = 11) that was absent in both *Trpm1^-/-^* (4.4 ± 0.6 pA, *n* = 8) and *Lrit3^-/-^* (4.2 ± 1.1 pA, *n* = 14) rod BCs ([Fig. 5*A*](#F5){ref-type="fig"}). The small residual current in both knock-outs has been observed previously, although its source remains unknown ([@B36]). We assessed excitatory input to *Lrit3^-/-^* OFF BCs, to determine whether it underlies the decreased glutamate release in the OFF sublamina. We first assessed AMPA/kainate receptor mediated currents in *Lrit3^-/-^* type 1 fluorescent OFF BCs. Kainate puffs evoked robust inward currents ([Fig. 5*B*](#F5){ref-type="fig"}) and the response amplitudes in control and *Lrit3^-/-^* BCs were similar (--39.7 ± 13.3 pA, *n* = 6 vs --33.7 ± 7.2 pA, *n* = 9, *t* test *p* = 0.67). Thus, the absence of LRIT3 eliminates mGluR6 mediated responses in DBCs, but does not impact the kainate mediated input to OFF BC1s.

![*Lrit3^-/-^*rod BCs lack functional Trpm1 responses and BC1 cells have decreased excitatory input. ***A***, Whole-cell voltage clamp recordings from rod BC from control, *Lrit3^-/-^* and *Trpm1^-/-^* mice during puffs of the mGluR6 antagonist CPPG (3 mM). Summary data shows a decreased response in *Lrit3^-/-^* (*n* = 11) and *Trpm1^-/-^* (*n* = 11) cells compared to control, consistent with absence of the ERG b-wave in these knock-outs (\*\*\*ANOVA, *F*~(2,30)~, *p* \< 0.001, Tukey *post hoc* tests, *p* \< 0.001 for control vs both knock-outs). ***B***, Responses from BC1 cells to kainate puffs (50 μm) in retinal slices from control and *Lrit3^-/-^* retinas. Summary data for all recorded cells shows no difference in the maximal responses between the two genotypes (*t* test, *p* = 0.67). ***C***, Whole-cell voltage clamp recordings of BC1 cell in control (top) and *Lrit3^-/-^* (bottom) mouse whole-mounts. Traces represent the current recorded at different holding potentials (ECl = --69 mV; Ecat = 0 mV). *Lrit3^-/-^* showed a marked absence of excitatory current (lower traces). ***D***, Light-evoked excitatory current response of an example control and *Lrit3^-/-^* BC1 cell. Traces show the average response to nine repeats of the square wave, contrast-reversing spot stimulus presented on a photopic background (1.2 × 10^4^ R\*/rod and cone/s; 150 μm in diameter, 1-Hz square wave, 100% Michelson contrast). ***E***, Summary data for the excitatory current response for all recorded BC1 cells (data partially shown in ***D***) control *n* = 4, three eyes; *Lrit3^-/-^ n* = 6, four eyes; *t* test *p* = 0.0072). ***F***, ***G***, As for ***D***, ***E***, for membrane voltage response recorded in current clamp mode (control *n* = 6, four eyes; *Lrit3^-/-^ n* = 3, three eyes; *t* test *p* = 0.0105). Error bars are mean ± SEM. \* = Significant difference.](enu9992031820005){#F5}

We examined the light evoked responses of BC1s using two-photon whole-cell recording in a whole-mount retinal preparation. Control BC1 responses to light stimuli showed robust excitatory and inhibitory currents, over a range of holding potentials (V~hold~; [Fig. 5*C*](#F5){ref-type="fig"}). The control response was characterized by an excitatory current to light decrements recorded at ECl (∼--60 mV) and an inhibitory current at Ecation (∼0 mV) to both light decrements and increments. This is consistent with the view that BC1s receive feed-forward excitation (OFF pathway-mediated), a combination of crossover ON inhibition likely mediated by ON pathway input from AII amacrine cells, and feed-forward inhibition via the OFF pathway. Excitatory currents in *Lrit3^-/-^* BC1s at light offset (OFF pathway input) were dramatically reduced compared to control (--9.1 ± 3.0 pA, *n* = 6; four eyes vs --46.5 ± 12.2 pA, *n* = 4; three eyes; *t* test, *p* = 0.0072), and the initial transient component was absent ([Fig. 5*D*,*E*](#F5){ref-type="fig"}). Membrane voltage responses recorded in current clamp mode showed substantial depolarization at light offset in control BC1s, which is absent in *Lrit3^-/-^* BC1s (22.0 ± 6.1 pA, *n* = 3; three eyes vs 2.7 ± 2.7 pA, *n* = 6; five eyes; *t* test, *p* = 0.0105; [Fig. 5*F*](#F5){ref-type="fig"}). Finally, the inhibitory currents in *Lrit3^-/-^* BC1s are desynchronized to the stimulus.

Taken together, we observe reduced excitatory responses in BC1s, although their response to exogenous kainate application is unaffected. In addition, glutamate release in *Lrit3^-/-^* IPL OFF sublamina ([Fig. 4*B*](#F4){ref-type="fig"}), excitatory signaling to OFF *Lrit3^-/-^* α RGCs and the majority of OFF RGC spiking responses are reduced. Combined the data strongly support the idea that LRIT3 is important for glutamate dynamics and/or sensing by OFF BCs in the synaptic cleft.

Discussion {#s5}
==========

In this report, we confirm and expand on the nature of the previously reported deficits in the ON pathway in the absence of LRIT3 ([@B35]; [@B28]; [@B15]). We now show that OFF pathway function also is severely impacted by the absence of LRIT3. The significant reduction in OFF BC function leads to abnormal OFF RGC excitatory inputs and spiking responses, which has not been reported either in *Lrit3^nob6^* or in two other CSNB1 mutant mouse models, *Nyx^nob^* and *Grm6^-/-^* ([@B7]; [@B21]).

Mutations in *LRIT3* were first identified from DNA samples of CSNB1 patients, using exome sequencing ([@B45]). ERG characterization of *Lrit3^-/-^* mouse retina (Extended Data [Fig. 1-1](#fig1-1){ref-type="supplementary-material"}; [@B35]; [@B28]) show a typical no ERG b-wave phenotype, similar to several other CSNB1 mouse models ([@B23]; [@B30]; [@B25]; [@B41]; [@B20]; [@B31]). This phenotype is consistent with the expression pattern of LRIT3 in the mouse retina, where it colocalizes with key DBC signalplex proteins, including nyctalopin, TRPM1, mGluR6, GPR179, nyctalopin, RGS7, RGS11, Gβ5, and R9AP ([Fig. 1](#F1){ref-type="fig"}; Extended Data [Figs. 1-1](#fig1-1){ref-type="supplementary-material"}, [1-2](#fig1-2){ref-type="supplementary-material"}; [@B35]; [@B27], [@B29]; [@B15]). The absence of LRIT3 expression has a negative impact on TRPM1 localization on rod DBC dendrites (Extended Data [Fig. 1-1](#fig1-1){ref-type="supplementary-material"}; [@B27]; [@B15]). From this result [@B27] concluded that TRPM1 expression depended on LRIT3 at the DBC synapse. We now extend this observation and our current results with previous results ([@B33]) and suggest that the loss of TRPM1 is likely secondary to the loss of nyctalopin from the DBC dendritic tips in *Lrit3^-/-^* mice ([Fig. 1](#F1){ref-type="fig"}), which is required for TRPM1 localization ([@B33]).

Further, our data suggest that nyctalopin insertion is likely because of a transsynaptic interaction between LRIT3 and nyctalopin ([Fig. 1](#F1){ref-type="fig"};[@B15]), which establishes a scaffold for assembly of TRPM1.

While nyctalopin and thus TRPM1, are absent from the tips of all DBCs, the situation with respect to the remaining DBC signalplex components is more complex. At the *Lrit3^-/-^* rod BCs dendritic tips, mGluR6, GPR179, RGS7, RGS11 and R9AP are all present, whereas they are absent from the cone DBC dendrites (Extended Data [Fig. 1-2](#fig1-2){ref-type="supplementary-material"}; [@B35]; [@B27]). Further, the absence of LRIT3 decreases, but does not eliminate, the PNA staining on cone terminals (Extended Data [Fig. 2-1](#fig2-1){ref-type="supplementary-material"}; [@B27]). LRIT3 is glycosylated, but the molecular composition of that glycosylation and whether PNA binds it is unknown. Our data suggest that LRIT3 has more complex interactions at the cone to cone DBCs than at the rod synapse. Given the impact of the absence of LRIT3 on light-driven input to the type 1 BCs (see below), it is possible LRIT3 disrupts aspects of cone synaptic function.

LRIT3 is required for both on and off pathway signaling in RGCs {#s5A}
---------------------------------------------------------------

The light-evoked *Lrit3^-/-^* RGCs responses to light onset are similar to RGCs responses characterized in several CSNB1 mouse lines *Nyx^nob^* ([@B7]), *Grm6^-/-^* ([@B37]; [@B34]; [@B32]; [Fig. 3](#F3){ref-type="fig"}), *Trpm1^-/-^* ([@B43]), and *Lrit3^-/-^* ([Fig. 3](#F3){ref-type="fig"}) and *Lrit3^nob6^* ([@B29]). *Lrit3^-/-^* mice, like most of these models show an increase in RGCs with spontaneous and no light evoked responses, most have no RGCs with ON responses comparable to control and the only ON responses have significantly delayed TTP. In *Grm6^-/-^* retina this input has been shown to arise from OFF BC input, via crossover signaling ([@B37]). Finally, like *Nyx^nob^* and *Trpm1^-/-^*, *Lrit3^-/-^* RGCs show a rhythmic bursting component in their spontaneous activity.

The defects in the OFF pathway are unique to the *Lrit3^-/-^* RGCs. The MEA surveys a large population of RGCs simultaneously, and we found that the peak amplitude of the OFF response is decreased compared to control OFF RGCs. Consistent with this change in the spiking response the excitatory currents in the OFF α RGCs also are reduced. Further, there is a reduction in the glutamate released in the OFF sublaminae of the *Lrit3^-/-^* IPL. A consequence of these affects is that even at the brightest stimulus intensities 60% of the *Lrit3^-/-^* RGCs are visually non-responsive compared to 19% in *Grm6^-/-^* and 2% in control retinas. The decrease in response amplitude and increase in NR RGCs in *Lrit3^-/-^* retinas can, in part, be attributed to the lack of ON input, but the large difference in the number of NR RGCs compared to of *Grm6^-/-^* retinas suggests an additional defect in *Lrit3^-/-^* OFF pathway signaling.

Zeitz and colleagues reported that the *Lrit3^nob6^* OFF RGCs had a delayed TTP ([@B29]). In contrast, we find a normal TTP in *Lrit3^-/-^* OFF RGCs measured using the MEA or by patch clamp recordings. The difference they observe arises from the distribution of their WT response latencies in their small dataset, which all are very fast. In contrast, while our larger dataset contains *Lrit3^-/-^* OFF RGCs with fast TTP, the distribution is broader and is not different from controls. Given the difference in TTP of OFF α (fast) and δ (slow) RGC excitatory currents ([Fig. 4*E*](#F4){ref-type="fig"}), it is possible that Neuillé and colleagues control dataset represent a different subpopulation than we record.

The interpretation of our recordings of excitatory currents in OFF α and OFF δ RGCs suggest signaling through the OFF pathway in *Lrit3^-/-^* retinas is complex. *Lrit3^-/-^* OFF α cells show a large decrease in light-evoked excitatory current compared to control, whereas the *Lrit3^-/-^* OFF δ cells are similar to controls. Of particular note is that the decrease in *Lrit3^-/-^* OFF-α cells (∼90%) is far greater than the decrease observed in control OFF-α cells recorded in the presence of L-AP4 (∼25% decrease in excitatory current ([@B4]). Furthermore, when control OFF δ cells are recorded in the presence of L-AP4, their excitatory currents actually increase ([@B4]). Based on these data we postulate that the different effects of the absence of LRIT3 on the OFF α and δ RGCs results from a direct decrease in excitatory input from OFF BCs combined with alterations in crossover inputs that differ between the types of RGC.

The role of LRIT3 in off pathway signaling in HBCs {#s5B}
--------------------------------------------------

The deficits in OFF RGC signaling, led us to examine potential dysfunction of *Lrit3^-/-^* OFF BCs and their excitatory inputs to OFF RGCs. We find that the kainate receptor mediated input to *Lrit3^-/-^* and control type 1 OFF BCs is similar, whereas the light evoked input to the *Lrit3^-/-^* BCs is significantly smaller than control. The decrease in glutamate release in the IPL and the decreased amplitude of OFF RGCs is consistent with a general decrease in HBC excitatory input. While the mechanism underlying the decreased excitatory input to OFF BCs requires further study, it is now clear that it does not reflect a defect in photoreceptor visual transduction because the *Lrit3^-/-^* scotopic and photopic a- waves are similar to controls (Extended Data [Fig. 1-1](#fig1-1){ref-type="supplementary-material"}). Thus, the first stage of altered signaling appears to be the glutamatergic transmission at the photoreceptor→BC synapse. This defect could arise from either structural alterations at the synapse or alterations in glutamate dynamics. Electron microscopy studies of the OPL from *Lrit3^nob6^* retinas indicate that there may be minor alterations to the invaginating synapse, although flat contacts were reportedly normal ([@B29]). Immunohistochemical studies of cone markers CACNA1F and mCAR also did not reveal any alterations in *Lrit3^-/-^* retinas (Extended Data [Fig. 2-1](#fig2-1){ref-type="supplementary-material"}). Because of the decrease in excitatory input to type 1 BCs we wondered if there were changes in glutamate release or uptake from the synapse. To examine this we used iGluSnFR expression in Mueller cells to measure glutamate dynamics in the OPL ([@B3]). We were unable to demonstrate any changes in the glutamate dynamics in the *Lrit3^-/-^* retinas with this method (unpublished data), although the challenging nature of these experiments precludes detection of subtle changes.

Finally, the fact that LRIT3 is expressed by rods ([@B15]), suggests this could be the case for cones and combined with the extensive loss of cone DBC signalplex components, it is possible that the absence of LRIT3 may also alter additional components critical to synaptic function. These issues remain to be elucidated in future studies.

Summary {#s5C}
-------

Our studies show that LRIT3 controls the localization of nyctalopin to the DBC dendritic tips, and that LRIT3 is crucial for normal excitatory input to OFF BCs. We propose that the dependence of the OFF pathway function on LRIT3 expression results from a dual role of LRIT3. First, it is required for normal assembly of the DBC signalplex, and second, for synaptic glutamate dynamics that decrease input to OFF BCs, and thus decreased excitatory responses in their postsynaptic OFF RGC targets.

Synthesis {#s6}
=========
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